
Opinion|Videos|July 12, 2024
Expert Insights on NSCLC: Unmet Needs and Innovations from ASCO 2024
Jason Porter, MD, outlines the most significant unaddressed challenges in treating and managing non-small cell lung cancer as the field approaches the American Society of Clinical Oncology's 2024 annual meeting.
Advertisement
Episodes in this series

Now Playing
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Concluded but ACA Subsidies in Limbo
2
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
3
FDA Approves Ziftomenib for R/R NPM1-Mutated AML
4
Nipocalimab Investigation Extends to Younger Patients: Jonathan Strober, MD
5















































